Table 2.
Comparison of pre and post-treatment parameters of participants
| Parameter | Baseline (n=37) | 6 th month (n=37) | P |
|---|---|---|---|
| 25(OH)D, ng/ml | 7.6 ± 5.9 | 31.8 ± 16.5 | < 0.001 |
| Hemoglobin, g/dl | 11.5 ± 1.2 | 10.6 ± 1.6 | 0.001 |
| Albumin, g/dl | 3.6 ± 0.4 | 3.7 ± 0.4 | 0.033 |
| Calcium, mg/dl | 8.61 ± 1.05 | 8.76 ± 1.05 | 0.121 |
| Phosphorus, mg/dl | 4.98 ± 1.14 | 4.87 ± 1.29 | 0.571 |
| Uric acid, mg/dl | 5.67 ± 1.21 | 5.65 ± 1.06 | 0.764 |
| Intact PTH, pg/ml | 573 ± 368 | 505 ± 367 | 0.093 |
| Kt/V | 1.9 ± 0.8 | 2.1 ± 1.2 | 0.264 |
| ASEX total score | 20.8 ± 7.72 | 22.2 ± 7.10 | 0.091 |
| Depression score | 7.5 ± 3.60 | 8.2 ± 3.88 | 0.225 |
| Anxiety score | 7.5 ± 4.04 | 7.2 ± 3.78 | 0.774 |
| Sleep score | 5.5 ± 2.63 | 7.3 ± 3.70 | 0.013 |
| Sexual dysfunction, n (%) | 32 (86.5) | 34 (91.9) | 0.687* |
| Depression, n (%) | 18 (48.6) | 19 (51.3) | 1.000* |
| Anxiety, n (%) | 7 (18.9) | 6 (16.2) | 1.000* |
| Sleep disorder, n (%) | 17 (45.9) | 25 (67.5) | 0.092* |
| Use of calcitriol, n (%) | 25 (67.6) | 26 (70.2) | 1.000* |
| Use of erythropoietin, n (%) | 27 (73) | 21 (56.8) | 0.070* |
Abbreviations: P, levels of significance; 25(OH)D, 25(OH) Vitamin D level; Kt/V, adequacy of dialysis; ASEX, Arizona Sexual Experiences Scale.
*
These p values are provided from Mc-Nemar test.